NCT00170768 - Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

May 31, 2005

Conditions

Healthy Volunteers

Interventions

DRUG

Darifenacin

Darifenacin modified release 7,5 mg tablets once daily titrated to 15 mg once daily

DRUG

Oxybutynin

Oxybutynin extended release 10 mg tablet once daily titrated to 15 mg, then to 20 mg once daily

DRUG

Placebo

Placebo once daily tablet (sham titration)

Trial Locations (1)

Washington Neuropsychological Institute LLC Georgetown, Washington D.C.